Dr. Joan Reibman, MD

  • New York, NY
  • Pulmonologist
NPI1265649933
Part D claims, 2024
889
Publications
93
Clinical trials
3
Hospital affiliations
1
Industry payments
$144,068
Practice address
462 First Avenue, New York, NY 10016
Practice phone
Call (212) 561-4132
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

NYC Health + Hospitals/Bellevue

Hospital · New York, New York

See all 1 affiliations

Find Dr. Reibman's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Joan Reibman is a pulmonologist in New York, New York

Dr. Reibman practices at NYC Health + Hospitals/Bellevue in New York, New York, part of NYC.

Dr. Reibman's NPI, 1265649933, was assigned on May 16, 2007. Dr. Reibman graduated from Johns Hopkins University School of Medicine in 1979. Dr. Reibman holds New York license 147102.

NPI and contact details
NPI enumeration date
May 16, 2007
NPI status
Active
Practice phone
(212) 561-4132
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Medical school graduation
1979

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data

Dr. Joan Reibman practices at NYC Health + Hospitals/Bellevue in New York, New York

Dr. Reibman's primary practice is NYC Health + Hospitals/Bellevue, at 462 First Avenue, New York, NY 10016 in New York County. The practice phone is (212) 561-4132.

Source: Dmand AI Affiliation Data

Dr. Joan Reibman is affiliated with 1 site of care

Dr. Reibman's primary practice is NYC Health + Hospitals/Bellevue in New York, New York, part of NYC. Dr. Reibman's employer is on file too: a hospital.

See Dr. Reibman's affiliation in Dmand AI

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Joan Reibman's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reibman practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
NYC Health + Hospitals/BellevueAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Reibman practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across NYC and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Joan Reibman is one of 1,056 pulmonologists in New York

Pulmonary disease is Dr. Reibman's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Reibman is licensed in New York.

Specialties and state licenses

  • Pulmonary disease, New YorkPrimaryLicense 147102 · taxonomy 207RP1001X

Pulmonologists near Dr. Reibman

Counts of pulmonologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Joan Reibman's patients have a median age of 68

Across all payers, Dmand AI patient panel data puts Dr. Reibman's median patient age at 68, with 77% women.

Dr. Reibman's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 68

Patient panel by sex, all payers

  • Women77%
  • Men23%

Source: Dmand AI Patient Panel Data

Dr. Joan Reibman wrote 889 Medicare Part D claims in 2024

In 2024, Dr. Reibman wrote 889 Medicare Part D claims for 115 patients. 49% of them were for generic drugs. CMS names the drug for 787 of them, across 20 drugs with 11 or more claims each, at $288,741 in total drug cost. In 2023, CMS named 988 claims across 20 drugs.

Part D claims, 2024889
Drugs named by CMS20
Total drug cost$288,741
Part D patients115

Dr. Reibman's Part D claims by kind of drug, 2024

  • Generic432 claims49%
  • Brand-name457 claims51%

Dr. Reibman's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 9882024: 78720%

Drugs named by CMS: 20 in 2024, 20 in 2023.

See all prescribing by Dr. Reibman

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

For MedTech and pharma teams

Find pulmonologists like Dr. Reibman by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Joan Reibman has 93 publications on record

Dmand AI links 93 papers to Dr. Reibman, published from 2010 to 2024. 2022 was the busiest year, with 12. The most frequent topics are September 11 Terrorist Attacks, New York City and Asthma. Dr. Reibman has published most often in Int J Environ Res Public Health. Dr. Reibman's most frequent co-authors are Kenneth Berger, MD, Robert Wise, MD and David A. Beuther, MD.

Papers93
Years published2010 to 2024

Dr. Reibman's papers by year, 2015 to 2024

Topics Dr. Reibman writes about most

  • September 11 Terrorist Attacks
  • New York City
  • Asthma
  • Dust
  • Environmental Exposure
  • Spirometry
  • Air Pollutants
  • Forced Expiratory Volume

Dr. Reibman's most frequent co-authors

Recent publications by Dr. Reibman

See all 93 publications and co-authors

See who Dr. Reibman researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Reibman works with, so you can find a warm path to the right pulmonologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Joan Reibman has worked on 3 clinical trials

Dmand AI links Dr. Reibman to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Asthma, Lung Diseases and Medication Adherence. NYU Langone Health sponsors the most, 2.

Conditions in Dr. Reibman's trials

  • Asthma
  • Lung Diseases
  • Medication Adherence
  • Patient Compliance
  • Respiratory Hypersensitivity

Investigators on the most trials with Dr. Reibman

Recent clinical trials with Dr. Reibman

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Joan Reibman received $144,068 in industry payments from 2016 to 2025

CMS Open Payments shows 152 general payments to Dr. Reibman from 4 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 87% of the total. AstraZeneca Pharmaceuticals LP paid the most, $135,416.

General payments to Dr. Reibman by program year, 2016 to 2025

General payments to Dr. Reibman by kind, 2016 to 2025

$144.1Kin total
  • Consulting fees$125,85187%
  • Travel and lodging$7,6945%
  • Speaker and faculty fees$6,9285%
  • Food and beverage$3,5342%
  • Education$620%

Companies that paid Dr. Reibman the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Reibman

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Joan Reibman graduated from Johns Hopkins University School of Medicine

Dr. Reibman graduated from Johns Hopkins University School of Medicine in 1979.

  1. Medical schoolJohns Hopkins University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Joan Reibman's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Joan Reibman

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Joan Reibman's NPI number?

Dr. Joan Reibman's NPI number is 1265649933. It was assigned on May 16, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Joan Reibman?

Dr. Joan Reibman is a pulmonologist in New York, New York. The primary specialty in the NPI Registry is Pulmonary Disease Physician (taxonomy code 207RP1001X).

Where does Dr. Joan Reibman practice?

Dr. Reibman practices at 462 First Avenue, New York, NY 10016. Dr. Reibman's primary practice is NYC Health + Hospitals/Bellevue in New York, New York, part of NYC.

What is Dr. Joan Reibman's office phone number?

The practice phone on file for Dr. Reibman is (212) 561-4132.

What is Dr. Joan Reibman's medical license number?

Dr. Reibman holds New York license 147102.

Which hospitals is Dr. Joan Reibman affiliated with?

Dr. Reibman practices at NYC Health + Hospitals/Bellevue in New York, New York.

Where did Dr. Joan Reibman go to medical school?

Dr. Reibman graduated from Johns Hopkins University School of Medicine in 1979.

What drugs does Dr. Joan Reibman prescribe most?

In 2024 Medicare Part D data, Dr. Reibman's most prescribed drugs by claims were Albuterol Sulfate Hfa, Prednisone and Fluticasone Propionate.

Has Dr. Joan Reibman received payments from drug or device companies?

CMS Open Payments shows $144,068 in general payments to Dr. Reibman from 4 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Joan Reibman been practicing?

Dr. Reibman graduated from medical school in 1979, 47 years ago.

Does Dr. Joan Reibman do research?

Dmand AI links 93 publications to Dr. Reibman, published from 2010 to 2024. Dr. Reibman has worked on 3 clinical trials.

Who does Dr. Joan Reibman publish with?

Dr. Reibman's most frequent co-authors are Kenneth Berger, MD (23 shared papers), Robert Wise, MD (11 shared papers) and David A. Beuther, MD (9 shared papers).

Selling to pulmonary disease practices?

See pulmonologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)